Keyphrases
HL-60 Cells
100%
Retinoic Acid
100%
Cell Differentiation
100%
Magnolol
100%
1,25-dihydroxyvitamin D3
100%
Human Leukemia Cells
100%
Honokiol
100%
All-trans Retinoic Acid
62%
CD14
25%
CD11b
25%
Acid Treatment
12%
Medicinal Plants
12%
SB203580
12%
Inhibitory Effect
12%
JNK Inhibitor
12%
JNK Pathway
12%
Cell Population
12%
SP600125
12%
Pharmacological Studies
12%
Antioxidant Properties
12%
P38 MAPK Pathway
12%
G(0)
12%
Magnolia Officinalis
12%
Differentiation Markers
12%
Lignans
12%
Enhancing Agents
12%
Cyclin-dependent Kinase Inhibitor
12%
MAPK Inhibitors
12%
Acute Promyelocytic Leukemia
12%
HL-60 Cell Differentiation
12%
Retinoic Acid-induced Differentiation
12%
P27Kip1
12%
PD098059
12%
MEK Inhibitor (MEKi)
12%
MEK Pathway
12%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Magnolol
100%
Retinoic Acid
100%
Honokiol
100%
Medicinal Plant
12%
2 (2 Amino 3 Methoxyphenyl)chromone
12%
SB 203580
12%
Stress Activated Protein Kinase Inhibitor
12%
Anti-Inflammatory Drug
12%
Antioxidant
12%
anthra[1,9 Cd]pyrazol 6(2h) One
12%
Lignan
12%
Mitogen Activated Protein Kinase Kinase Inhibitor
12%
Magnolia Officinalis
12%
Cyclin Dependent Kinase Inhibitor
12%
Promyelocytic Leukemia
12%
Biochemistry, Genetics and Molecular Biology
Tretinoin
100%
Retinoic Acid
100%
Cellular Differentiation
100%
Honokiol
100%
Low Drug Dose
25%
CD14
25%
P38 Mitogen-Activated Protein Kinases
25%
Medicinal Plant
12%
Cyclin-Dependent Kinase
12%
MEK Inhibitor
12%
Magnolia Officinalis
12%